Skip to main content

BRIEF RESEARCH REPORT article

Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1466234
This article is part of the Research Topic The Role of Nod-Like Receptor (NLR) Family of Proteins in Inflammation View all articles

Sex-specific NLRP3 activation in neutrophils promotes neutrophil recruitment and NETosis in the murine model of diffuse alveolar hemorrhage

Provisionally accepted
Pierre-André Jarrot Pierre-André Jarrot 1,2Jiyoun Kim Jiyoun Kim 1,2William Chan William Chan 1,2Lukas Heger Lukas Heger 1,2,3Nicolas Schommer Nicolas Schommer 1,2Pierre Cunin Pierre Cunin 4Camila M. Silva Camila M. Silva 1,2Stephane Robert Stephane Robert 5Peter A. Nigrovic Peter A. Nigrovic 4Bruce Ewenstein Bruce Ewenstein 1,2Denisa Wagner Denisa Wagner 1,2*
  • 1 Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States
  • 2 Departments of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States
  • 3 Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany
  • 4 Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • 5 Centre de recherche en CardioVasculaire et Nutrition, Faculté des Sciences Médicales et Paramédicales, Aix-Marseille Université, Marseille, Provence-Alpes-Côte d'Azur, France

The final, formatted version of the article will be published soon.

    Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus and small vessel vasculitis. We previously showed that neutrophil extracellular traps (NETs) were associated with the pathogenesis of pristane-induced DAH and demonstrated that neutrophil NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome assembly participated in NET generation under sterile stimulation. We investigated whether NLRP3 inflammasome assembly in neutrophils may drive pulmonary NETosis in a mouse model of pristane-induced DAH.C57BL/6J mice received a single intraperitoneal injection of 0.5mL of pristane. Neutrophil NLRP3 inflammasome assembly and NETs were characterized by immunofluorescence staining of apoptosisassociated speck-like protein a CARD (ASC), co-staining of DNA, and citrullinated histones, respectively. Clinical status of mice was assessed 11 days after pristane injection by measurement of arterial oxygen saturation and of weight loss; severity of lung injury was determined using a quantification score from hematoxylin-eosin-stained slides.Pristane induced ASC speck formation in neutrophils and we confirmed that NLRP3 inflammasome was involved in NET generation after pristane stimulation in vitro. NLRP3 deficiency reduced the severity of pristane-induced DAH in female, but not male mice. Interestingly, NLRP3 deficiency reduced the number of neutrophils and NETs in the lungs of females compared to males.Our results suggest a link between female sex-specific NLRP3 inflammasome activation and subsequent pulmonary NETosis in the development of pristane-induced DAH. Therefore, we identified NLRP3 inflammasome as a potential new therapeutic target in this severe complication of pro-female autoimmune disease for which specific inhibitors of NLRP3 are currently developed.

    Keywords: NLRP3 inflammasome, neutrophil extracellular traps, Diffuse alveolar hemorrhage, sexspecific, murine model

    Received: 17 Jul 2024; Accepted: 04 Nov 2024.

    Copyright: © 2024 Jarrot, Kim, Chan, Heger, Schommer, Cunin, Silva, Robert, Nigrovic, Ewenstein and Wagner. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Denisa Wagner, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.